Covestro Past Earnings Performance
Past criteria checks 0/6
Covestro's earnings have been declining at an average annual rate of -35%, while the Chemicals industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 6.2% per year.
Key information
-35.0%
Earnings growth rate
-35.5%
EPS growth rate
| Chemicals Industry Growth | 6.0% |
| Revenue growth rate | 6.2% |
| Return on equity | -4.0% |
| Net Margin | -1.8% |
| Next Earnings Update | 26 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Covestro makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 14,149 | -261 | 1,846 | 364 |
| 30 Jun 24 | 14,114 | -325 | 1,851 | 365 |
| 31 Mar 24 | 14,144 | -207 | 1,854 | 360 |
| 31 Dec 23 | 14,377 | -198 | 1,865 | 374 |
| 30 Sep 23 | 14,995 | -910 | 1,900 | 372 |
| 30 Jun 23 | 16,045 | -867 | 1,932 | 369 |
| 31 Mar 23 | 17,028 | -714 | 1,960 | 372 |
| 31 Dec 22 | 17,968 | -272 | 1,975 | 361 |
| 30 Sep 22 | 18,342 | 929 | 1,977 | 359 |
| 30 Jun 22 | 18,026 | 1,389 | 1,974 | 371 |
| 31 Mar 22 | 17,279 | 1,639 | 1,931 | 362 |
| 31 Dec 21 | 15,903 | 1,616 | 1,861 | 341 |
| 30 Sep 21 | 14,572 | 1,626 | 1,759 | 330 |
| 30 Jun 21 | 13,030 | 1,333 | 1,653 | 298 |
| 31 Mar 21 | 11,230 | 832 | 1,527 | 270 |
| 31 Dec 20 | 10,706 | 459 | 1,529 | 262 |
| 30 Sep 20 | 10,563 | 184 | 1,593 | 253 |
| 30 Jun 20 | 10,965 | 152 | 1,649 | 254 |
| 31 Mar 20 | 12,020 | 393 | 1,756 | 263 |
| 31 Dec 19 | 12,412 | 552 | 1,783 | 266 |
| 30 Sep 19 | 12,820 | 594 | 1,809 | 275 |
| 30 Jun 19 | 13,360 | 943 | 1,852 | 276 |
| 31 Mar 19 | 14,012 | 1,358 | 1,905 | 276 |
| 31 Dec 18 | 14,616 | 1,823 | 1,924 | 276 |
| 30 Sep 18 | 14,866 | 2,310 | 1,922 | 275 |
| 30 Jun 18 | 14,696 | 2,305 | 1,897 | 278 |
| 31 Mar 18 | 14,331 | 2,185 | 1,859 | 278 |
| 31 Dec 17 | 14,138 | 2,009 | 1,859 | 274 |
| 30 Sep 17 | 13,633 | 1,567 | 1,874 | 267 |
| 30 Jun 17 | 13,123 | 1,335 | 1,860 | 266 |
| 31 Mar 17 | 12,615 | 1,081 | 1,846 | 260 |
| 31 Dec 16 | 11,904 | 795 | 1,815 | 259 |
| 30 Sep 16 | 11,685 | 587 | 1,755 | 261 |
| 30 Jun 16 | 11,683 | 488 | 1,708 | 257 |
| 31 Mar 16 | 11,903 | 410 | 1,691 | 258 |
| 31 Dec 15 | 12,082 | 343 | 1,640 | 256 |
| 30 Sep 15 | 12,264 | 422 | 1,593 | 243 |
| 30 Jun 15 | 12,306 | 361 | 1,568 | 228 |
| 31 Mar 15 | 11,956 | 298 | 1,483 | 220 |
| 31 Dec 14 | 11,761 | 272 | 1,448 | 214 |
| 31 Dec 13 | 11,357 | 180 | 1,441 | 222 |
Quality Earnings: 029178035 is currently unprofitable.
Growing Profit Margin: 029178035 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 029178035 is unprofitable, and losses have increased over the past 5 years at a rate of 35% per year.
Accelerating Growth: Unable to compare 029178035's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 029178035 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.7%).
Return on Equity
High ROE: 029178035 has a negative Return on Equity (-4.03%), as it is currently unprofitable.